Search hospitals > Louisiana > New Orleans
Louisiana State University Health Science Center
Claim this profileNew Orleans, Louisiana 70112
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
254 reported clinical trials
21 medical researchers
Summary
Louisiana State University Health Science Center is a medical facility located in New Orleans, Louisiana. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. Louisiana State University Health Science Center is involved with conducting 254 clinical trials across 522 conditions. There are 21 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 positive
Stage IV
Top PIs
Scott E. DelacroixLSU Healthcare Network / Metairie Multi-Specialty Clinic5 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Prostate Cancer
28 reported clinical trials
63 drugs studied
Brian C. BoulmayUniversity Medical Center New Orleans6 years of reported clinical research
Studies Lung Cancer
Studies Parotid Gland Cancer
19 reported clinical trials
31 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Parotid Gland Cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Agustin Garcia, M.D.University Medical Center New Orleans8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Clinical Trials running at Louisiana State University Health Science Center
Breast Cancer
Bladder Cancer
Lung Cancer
Kidney Cancer
Parotid Gland Cancer
Breast cancer
Bladder Carcinoma
Cancer
Squamous Cell Carcinoma
Prostate Cancer
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Louisiana State University Health Science Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.